Acumen Pharmaceuticals (NASDAQ:ABOS – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02), Zacks reports. During the same period in the previous year, the company posted ($0.28) EPS. Acumen Pharmaceuticals Stock Down 2.4 % Acumen Pharmaceuticals stock traded […]

Related Keywords

, Acumen Pharmaceuticals , Acumen Pharmaceuticals Inc , Earnings History For Acumen Pharmaceuticals , News Ratings For Acumen Pharmaceuticals Daily , Acumen Pharmaceuticals Stock Down , Get Free Report , Pharmaceuticals Stock Down , Acumen Pharmaceuticals Daily ,